Simplifying Global Compliance
FDAnews Device Daily Bulletin
nContact Gets IDE to Research Closed-Chest Convergent Ablation Procedure
April 20, 2010
nContact Surgical, Inc Monday announced it has received the
first Investigational Device Exemption (IDE) from the U.S. Food and Drug Administration to evaluate the safety and efficacy of a combined surgical and
catheter procedure (the convergent procedure) to treat patients with longstanding persistent atrial fibrillation.
Copyright ©2017. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing